StockData
Petros Pharmaceuticals, Inc. logo

Petros Pharmaceuticals, Inc. (PTPI) stock

PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$0.00+0.00 (+5.56%)

Close on Oct 19, 2026Market cap $135.07KP/E –Yield –

Petros Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Petros Pharmaceuticals's gross profit for the twelve months ending Dec 31, 2024 was $3.90M, down 7.0% year over year. For fiscal 2024 it was $3.90M, down 7.0% from the year before. The highest annual figure on record is $6.21M in fiscal 2021.

Annual gross profit

PeriodPeriod endValueChange
FY2024Dec 31, 2024$3.90M-7.0%
FY2023Dec 31, 2023$4.19M+13.2%
FY2022Dec 31, 2022$3.70M-40.4%
FY2021Dec 31, 2021$6.21M+12.7%
FY2020Dec 31, 2020$5.51M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$460.65K–
Q3 FY2024Sep 30, 2024$1.29M+1.8%
Q2 FY2024Jun 30, 2024$1.09M-26.2%
Q1 FY2024Mar 31, 2024$1.06M-46.3%
Q4 FY2023Dec 31, 2023-$522.40K–
Q3 FY2023Sep 30, 2023$1.27M–
Q2 FY2023Jun 30, 2023$1.48M-58.2%
Q1 FY2023Mar 31, 2023$1.97M-1.3%
Q4 FY2022Dec 31, 2022-$83.23K-104.0%
Q3 FY2022Sep 30, 2022-$1.74M-150.8%
Q2 FY2022Jun 30, 2022$3.54M+197.8%
Q1 FY2022Mar 31, 2022$1.99M-19.7%
Q2 FY2021Jun 30, 2021$2.06M+147.4%
Q1 FY2021Mar 31, 2021$3.43M+240.5%
Q4 FY2020Dec 31, 2020$1.19M–
Q3 FY2020Sep 30, 2020$2.48M–
Q2 FY2020Jun 30, 2020$834.33K–
Q1 FY2020Mar 31, 2020$1.01M–

More Petros Pharmaceuticals figures

See a number that looks wrong?